All In Biotech

Free tool

FAERS Monitor: Actigall

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019594 or its brand name (Actigall, Ursodiol). Reports on generic versions are filed under their own applications.

Reports

19,985

Serious

15,684

78% of reports

Hospitalization

8,980

Death reported

2,483

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,828
  • pruritus1,282
  • diarrhoea1,130
  • fatigue1,095
  • nausea1,003
  • drug ineffective959
  • pyrexia847
  • pneumonia710
  • death705
  • vomiting661
  • headache611
  • dyspnoea569
  • abdominal pain533
  • asthenia502
  • dizziness485

Reports by year received

View as table
YearReports
200435
2005137
200666
2007113
2008175
2009173
2010229
2011367
2012387
2013214
2014274
2015417
2016578
2017888
20181,386
20191,255
20201,321
20211,577
20222,196
20232,009
20242,075
20252,360
20261,753

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,174 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pruritusSignal1,2823.53.32,345
pyrexiaSignal8472.62.4830
abdominal painSignal5332.42.2444
pneumoniaSignal7102.32.1534
off label useSignal1,8282.22.11,244
diarrhoea1,1301.81.7449
fatigue1,0951.51.4177
vomiting6611.51.4105
asthenia5021.41.359
nausea1,0031.31.387
dyspnoea5691.11.02
headache6111.00.90
dizziness4851.00.90
death7050.90.816
drug ineffective9590.80.773

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.